Allogene Therapeutics
Dustin W. is an experienced finance professional currently serving as Associate Director of Accounting Operations at Allogene Therapeutics since August 2019, having previously held titles including Senior Accounting Operations Manager and Accounting Operations Manager at the same company. Prior to Allogene Therapeutics, Dustin W. worked as a Senior Accountant at Pacific Biosciences and ForeScout Technologies Inc., as well as a Senior Audit Associate and Audit Associate at KPMG. Dustin W.'s career began with a role as an Assistant Language Teacher in the Japan Exchange and Teaching Program(me) from August 2014 to August 2015. Dustin W. holds a Bachelor of Arts degree in Business Economics/Accounting and Japanese from UC Santa Barbara.
This person is not in any teams
This person is not in any offices
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.